- Protocol Short Name and Number: Follicular NHL, 0701
- Protocol Long Name: Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin’s Lymphoma Beyond First Complete Response
- Protocol (PDF)
- Informed Consent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0701 Protocol Chair: Ginna Laport, MD
- BMT CTN # 0701 Protocol Officer: Marcie Tomblyn, MD
- BMT CTN # 0701 Medical Monitor: Gabrielle Meyers, MD
- BMT CTN # 0701 Protocol Coordinator: bmtctn@emmes.com
- Keywords: Follicular, Non-Hodgkin’s Lymphoma, NHL, Lymphoma, Allogeneic Transplant, Allo Transplant, Allo, Quality of Life, QOL, Fludarabine, Cyclophosphamide, Rituximab, FCR, Non-Myeloablative, Unrelated, Unrelated Donor, Pediatric, Child, Children, Teen, Adolescent
This study reached its target patient accrual on October 22, 2012 and is closed to new enrollment.